Prescribing Anti-Psychotics?
Auto screen your patients for Tardive Dyskinesia — for free.
Empower early detection and uphold standards of care with TDScreen — the only AI-powered, video-based tool built on the AIMS standard.
Screen More Patients. Maintain Higher Standards. Deliver Better Care.
TDScreen is a virtual screening tool designed to identify potential TD symptoms and severity quickly, accurately, and with minimal disruption to provider workflows.
- AI-based video analysis: 5-minute, at-home screening. HIPAA-compliant.
- AIMS-style evaluation: Scores are determined by specific regions—similar to those in the AIMS assessment.
- Automated follow-up: Monitor patients continuously with built-in screening cadences.
- Real-time results: Instantly access results to inform your next steps.
- Scale with your team: We support multi-location rollouts, provider onboarding, and secure data exchange.
up to
1 in 4
individuals taking specific antipsychotic medications may develop TD.2
in as early as
3 months
You can’t manage what you don’t screen.
Screening for TD is often delayed — or skipped altogether. Failing to screen routinely puts patients at risk of undetected progression and exposes providers to clinical liability and compliance gaps. In today’s behavioral health landscape, meeting screening standards isn’t optional — it’s essential.
How TDScreen Works
The TDScreen tool is based on the Abnormal Involuntary Movement Scale (AIMS), a comprehensive clinician-rated scale designed to specifically evaluate orofacial movements. Employing advanced AI video technology, TDScreen efficiently assesses and quantifies symptom presence and severity of tardive dyskinesia in less than 5 minutes. The resulting score generated by this screening can aid in clinical decision-making and management strategies.
Sign Up
Request access and grant us the ability to share your patients’ results with you.
Patient Enrollment
Collaborate with our team to enroll your eligible patients for regular automated screenings.
Patient Takes TDScreen
Patients complete a TDScreen at home on a personal device— it takes 5 minutes or less.
Receive Instant Results
Results will appear in our secure provider portal and can help inform follow-up.
Start Screening your Patients Today with TDScreen
Clinicians can now access our FREE online platform, TDScreen, designed to streamline TD symptom screening and improve patient care.
Seamlessly integrate automated TDScreen protocols alongside other essential screening and monitoring programs (additional fees may apply).
Join us today to scale patient care and improve health outcomes effortlessly.
FAQ
Yes. TDScreen is completely free for providers and patients to use. There are no hidden fees.
Any licensed prescribing behavioral health provider treating patients on antipsychotic medications — including psychiatrists, psychiatric NPs, etc. Commonly used in settings such as private clinics, community-based services like CCBHCs, hospitals, and more. Available for individual providers, group practices, and multi-site organizations. Full implementation support included.
Yes—patients find the experience quick, simple, and non-intimidating. Most complete the screen in under five minutes.
We have a very high level of predictability and sensitivity. We’re happy to share model cards or AUC data in a follow-up.
Most providers are live within 48 hours. For multi-provider or multi-site organizations, we’ll help onboard your team and align screening workflows.
A BAA is not required to use TDScreen, but it is necessary to access the full suite of features—including the Provider Portal, which offers real-time visibility into your patients’ results.
If you’re unable to sign a BAA, no problem—you can still use TDScreen! We’ll provide you with a unique, secure link to share with patients. They can use this link to access and complete the TDScreen independently, receive their results, and then share those results with you.
You will receive a clinically structured summary of their results, making it easy to determine next steps. TDScreen is designed to support—not replace—your clinical judgment and offers clear guidance for follow-up conversations.
Yes. There’s no contract, no cost, and no obligation. You’re free to discontinue at any time.
TDScreen meets all common regulatory requirements. It is HIPAA-compliant and SOC 2 Type II certified. We securely manage PHI under industry best practices.
The next generation of measured-based patient care — powered by video, text and audio.
Disclaimer: TDScreen is intended for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Its intended use is to provide a preliminary estimate of the potential risk for Tardive Dyskinesia for people currently taking or have taken Neuroleptic medications (also known as anti-psychotics). Other potential causes of tardive dyskinesia include certain anti-depressants and mood stabilizers, certain anti-nausea medications, certain anti-seizure medications, decongestants such as pseudoephedrine and phenylephrine, medications for movement disorders. People who have been diagnosed with Parkinson’s, Huntington’s, or any other movement disorder should not use TDScreen. The results generated by this screener do not constitute medical advice or a diagnosis and should not be used as a basis for self-diagnosis or self-treatment. Any reliance on the results of this screener should be accompanied by seeking guidance from a qualified healthcare professional for a comprehensive evaluation and diagnosis. If you are experiencing symptoms or concerns related to Tardive Dyskinesia or any other medical condition, please consult with a licensed medical professional for appropriate assessment and care. Only available in the United States.
© 2024 Videra Health, Inc. All rights reserved. Stock photos used.